ID   FER_DROME               Reviewed;        1325 AA.
AC   P18106; Q27576; Q86P62; Q8INP1; Q8INP2; Q9TYI1; Q9VHE7; Q9VHE8;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 3.
DT   07-APR-2021, entry version 213.
DE   RecName: Full=Tyrosine-protein kinase Fer;
DE            EC=2.7.10.2;
GN   Name=FER {ECO:0000312|FlyBase:FBgn0000723};
GN   Synonyms=fps {ECO:0000312|FlyBase:FBgn0000723},
GN   Fps85D {ECO:0000312|FlyBase:FBgn0000723},
GN   HD-179 {ECO:0000312|FlyBase:FBgn0000723};
GN   ORFNames=CG8874 {ECO:0000312|FlyBase:FBgn0000723};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Embryo, and Head;
RX   PubMed=1898762; DOI=10.1128/mcb.11.1.226;
RA   Katzen A.L., Montarras D., Jackson J., Paulson R.F., Kornberg T.,
RA   Bishop J.M.;
RT   "A gene related to the proto-oncogene fps/fes is expressed at diverse times
RT   during the life cycle of Drosophila melanogaster.";
RL   Mol. Cell. Biol. 11:226-239(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS B AND D), AND SUBCELLULAR LOCATION.
RC   TISSUE=Embryo, and Head;
RX   PubMed=9038371; DOI=10.1038/sj.onc.1200875;
RA   Paulson R.F., Jackson J., Immergluck K., Bishop J.M.;
RT   "The DFer gene of Drosophila melanogaster encodes two membrane-associated
RT   proteins that can both transform vertebrate cells.";
RL   Oncogene 14:641-652(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   STRAIN=Berkeley; TISSUE=Head;
RA   Stapleton M., Brokstein P., Hong L., Agbayani A., Carlson J.W., Champe M.,
RA   Chavez C., Dorsett V., Dresnek D., Farfan D., Frise E., George R.A.,
RA   Gonzalez M., Guarin H., Kronmiller B., Li P.W., Liao G., Miranda A.,
RA   Mungall C.J., Nunoo J., Pacleb J.M., Paragas V., Park S., Patel S.,
RA   Phouanenavong S., Wan K.H., Yu C., Lewis S.E., Rubin G.M., Celniker S.E.;
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1191-1241.
RX   PubMed=9731193; DOI=10.1006/bbrc.1998.9003;
RA   Oates A.C., Wollberg P., Achen M.G., Wilks A.F.;
RT   "Sampling the genomic pool of protein tyrosine kinase genes using the
RT   polymerase chain reaction with genomic DNA.";
RL   Biochem. Biophys. Res. Commun. 249:660-667(1998).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=16831834; DOI=10.1242/dev.02467;
RA   Murray M.J., Davidson C.M., Hayward N.M., Brand A.H.;
RT   "The Fes/Fer non-receptor tyrosine kinase cooperates with Src42A to
RT   regulate dorsal closure in Drosophila.";
RL   Development 133:3063-3073(2006).
CC   -!- FUNCTION: Tyrosine-protein kinase which is required during
CC       embryogenesis for formation of the actin cable in leading edge cells of
CC       the dorsal epidermis and for the timely progression of dorsal closure.
CC       May play a role in regulation of adherens junctions and cell adhesion
CC       through phosphorylation of the beta-catenin arm.
CC       {ECO:0000269|PubMed:16831834}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:9038371}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:9038371}. Cell junction, adherens
CC       junction {ECO:0000269|PubMed:9038371}. Note=At stages 11-12 of
CC       embryogenesis, localizes to adherens junctions in epidermal cells. At
CC       stages 13-14, is no longer detected in the epidermal cell junctions
CC       which border with the amnioserosa. {ECO:0000269|PubMed:16831834}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=A;
CC         IsoId=P18106-4; Sequence=Displayed;
CC       Name=B; Synonyms=p92;
CC         IsoId=P18106-1; Sequence=VSP_004988;
CC       Name=C;
CC         IsoId=P18106-3; Sequence=VSP_004987, VSP_004988;
CC       Name=D; Synonyms=p45;
CC         IsoId=P18106-2; Sequence=VSP_004986;
CC   -!- TISSUE SPECIFICITY: Expressed in a subset of cells in the embryonic
CC       central nervous system (CNS) (PubMed:16831834). In the embryo,
CC       expressed in leading edge cells of the dorsal epidermis (at protein
CC       level) (PubMed:16831834). Expressed in many tissues during embryonic
CC       development, some expression is transient and absent from most of
CC       nervous system (PubMed:1898762). In the embryo, strong expression in
CC       the leading edge cells from late stage 13 and throughout dorsal closure
CC       to the end of stage 15 (PubMed:16831834). In the embryonic CNS,
CC       expressed in the midline glia from stage 13, and by stage 16 expressed
CC       in a segmentally repeated subset of cells and in the dMP2 neurons
CC       (PubMed:16831834). Larvae exhibit expression in neural tissues and
CC       graded expression in all imaginal disks (PubMed:1898762). Pupal
CC       expression is seen in muscles and varies during development
CC       (PubMed:1898762). Expression in adults is strong in the retina and
CC       present in ovaries, no expression is present in the adult brain
CC       (PubMed:1898762). {ECO:0000269|PubMed:16831834,
CC       ECO:0000269|PubMed:1898762}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during all stages of development.
CC       {ECO:0000269|PubMed:1898762}.
CC   -!- DISRUPTION PHENOTYPE: 53% of mutants die during embryogenesis with the
CC       remainder dying during larval and pupal development. In embryos the
CC       rate of dorsal closure is reduced and complete closure is delayed until
CC       after stage 16. During dorsal closure, filopodia are normal but the
CC       actomyosin cable is reduced and the leading edge cells have an
CC       irregular morphology. After dorsal closure, a very small percentage of
CC       embryos display a small anterior hole in their cuticle. Reduced
CC       phosphorylation of arm. {ECO:0000269|PubMed:16831834}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Fes/fps subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA93470.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA37036.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X52844; CAA37036.1; ALT_FRAME; mRNA.
DR   EMBL; U50450; AAA93470.1; ALT_FRAME; mRNA.
DR   EMBL; AE014297; AAF54366.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAF54367.3; -; Genomic_DNA.
DR   EMBL; AE014297; AAN13420.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAN13421.1; -; Genomic_DNA.
DR   EMBL; BT003462; AAO39465.1; -; mRNA.
DR   EMBL; AJ002916; CAA05751.1; -; Genomic_DNA.
DR   PIR; A39670; OKFFPS.
DR   RefSeq; NP_524288.3; NM_079564.4. [P18106-4]
DR   RefSeq; NP_731341.1; NM_169274.2. [P18106-1]
DR   RefSeq; NP_731342.1; NM_169275.2. [P18106-3]
DR   RefSeq; NP_731343.1; NM_169276.2. [P18106-2]
DR   SMR; P18106; -.
DR   BioGRID; 66283; 8.
DR   IntAct; P18106; 11.
DR   STRING; 7227.FBpp0081530; -.
DR   PaxDb; P18106; -.
DR   PRIDE; P18106; -.
DR   EnsemblMetazoa; FBtr0082051; FBpp0081529; FBgn0000723. [P18106-1]
DR   EnsemblMetazoa; FBtr0082052; FBpp0081530; FBgn0000723. [P18106-4]
DR   EnsemblMetazoa; FBtr0082053; FBpp0081531; FBgn0000723. [P18106-3]
DR   EnsemblMetazoa; FBtr0082054; FBpp0081532; FBgn0000723. [P18106-2]
DR   GeneID; 41118; -.
DR   KEGG; dme:Dmel_CG8874; -.
DR   CTD; 2241; -.
DR   FlyBase; FBgn0000723; FER.
DR   eggNOG; KOG0194; Eukaryota.
DR   GeneTree; ENSGT00940000168715; -.
DR   HOGENOM; CLU_005265_1_0_1; -.
DR   InParanoid; P18106; -.
DR   BRENDA; 2.7.10.2; 1994.
DR   SignaLink; P18106; -.
DR   BioGRID-ORCS; 41118; 0 hits in 3 CRISPR screens.
DR   ChiTaRS; FER; fly.
DR   GenomeRNAi; 41118; -.
DR   PRO; PR:P18106; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0000723; Expressed in head and 24 other tissues.
DR   ExpressionAtlas; P18106; baseline and differential.
DR   Genevisible; P18106; DM.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0005543; F:phospholipid binding; ISM:FlyBase.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISS:FlyBase.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:RHEA.
DR   GO; GO:0051017; P:actin filament bundle assembly; IMP:FlyBase.
DR   GO; GO:0007411; P:axon guidance; IMP:FlyBase.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0007391; P:dorsal closure; IGI:FlyBase.
DR   GO; GO:0046664; P:dorsal closure, amnioserosa morphology change; IMP:FlyBase.
DR   GO; GO:0007394; P:dorsal closure, elongation of leading edge cells; IMP:FlyBase.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   CDD; cd10361; SH2_Fps_family; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR035849; Fes/Fps/Fer_SH2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell junction; Coiled coil;
KW   Developmental protein; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; SH2 domain; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN           1..1325
FT                   /note="Tyrosine-protein kinase Fer"
FT                   /id="PRO_0000088095"
FT   DOMAIN          1..264
FT                   /note="F-BAR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01077"
FT   DOMAIN          960..1051
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          1063..1318
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         1069..1077
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        1185
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         1092
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         1213
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..932
FT                   /note="Missing (in isoform D)"
FT                   /evidence="ECO:0000303|PubMed:9038371"
FT                   /id="VSP_004986"
FT   VAR_SEQ         1..329
FT                   /note="Missing (in isoform C)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004987"
FT   VAR_SEQ         426..946
FT                   /note="Missing (in isoform B and isoform C)"
FT                   /evidence="ECO:0000303|PubMed:1898762,
FT                   ECO:0000303|PubMed:9038371"
FT                   /id="VSP_004988"
FT   CONFLICT        58
FT                   /note="I -> T (in Ref. 1; CAA37036)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        230..248
FT                   /note="ILQEAAQYGDLTADKYKEI -> TCRRRPSMATSRPTSTRRF (in Ref.
FT                   1; CAA37036)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        320..341
FT                   /note="GAVRDCQEKQMKMIEHVNGGSP -> EPSGLPGEADEDDRACEWWLA (in
FT                   Ref. 1; CAA37036)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        364
FT                   /note="S -> D (in Ref. 1; CAA37036)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        940
FT                   /note="V -> W (in Ref. 2; AAA93470)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1050
FT                   /note="P -> T (in Ref. 1; CAA37036 and 2; AAA93470)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1161
FT                   /note="Q -> E (in Ref. 1; CAA37036 and 2; AAA93470)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1325 AA;  150263 MW;  7DFC98D9B9776E78 CRC64;
     MGFSSALQSR AAHEALIVRQ DAELRLMETM KRSIQMKAKC DKEYAISLTA VAQQGLKIDR
     ADEMQGSLIS KSWRSYMDEL DHQAKQFKFN AEQLEVVCDK LTHLSQDKRK ARKAYQEEHA
     KIAARLNHLT DEVVRKKSEY QKHLEGYKAL RTRFEENYIK APSRSGRKLD DVRDKYQKAC
     RKLHLTHNEY VLSITEAIEV EKDFRNVLLP GLLEHQQSVQ ESFILLWRNI LQEAAQYGDL
     TADKYKEIQK RIDTVIGSIN PTEEYGEFTE KYKTSPTTPL LFQFDETLIQ DIPGKLQSST
     LTVDNLTVDW LRNRLQELEG AVRDCQEKQM KMIEHVNGGS PVANGSIISN GSNTSNGIQS
     NKDSLCRQSK DLNALRCQEK QKQKLVDMIK CALNEVGCEE LPSGCDDDLT LEQNFIENGY
     NNEQQRSNST SSPGLGIMNE LMRRGGVLTL LRGRGRHFKR KSTPQPATPM TRSRQGRFNK
     LQPRSQSLGS LSVIRDGNGP SPARYEPITN HRLRQAASVH YLGEEIATSS TNPPDLTRLR
     RTQCSMLCLG EDEEPVVLAS PAPLTQLTAA VLTNTNNNHI YADLELDKKK DTSPSPECKG
     EQIQPKKEQI RIEINQTAPQ NSIDAHLDRI DELNRVLDDR LKRTLQPSDD VNAIESAEEN
     HIQTRKLAKD PDSQTKRSSS SSSECRSSKD TSHSKKRSLS FSQKSISNIF SNLKEFSKSP
     LVRMGKNHIL NEEQDAKRTQ PSQHHHSSGS DCPTNSSSSS SNNNNNNKNT SSNSNHSASQ
     STIITSTITT TITTTTTTTP SKENSRLKFK VPKIQKKSKA IRNTFRSKLL NFQLKRSKPC
     KQCTKRRRIH PSKSVFDFAK EFEVEQPAGS AADEQFCNCP PAGQKPVKPS VQISGHKDHP
     FESSSGELDE NSDRDIDNDE EEEDSASDDV LSMKDHCYCV PSLAASISLS TNRPLYEEEW
     FHGVLPREEV VRLLNNDGDF LVRETIRNEE SQIVLSVCWN GHKHFIVQTT GEGNFRFEGP
     PFASIQELIM HQYHSELPVT VKSGAILRRP VCRERWELSN DDVVLLERIG RGNFGDVYKA
     KLKSTKLDVA VKTCRMTLPD EQKRKFLQEG RILKQYDHPN IVKLIGICVQ KQPIMIVMEL
     VLGGSLLTYL RKNSNGLTTR QQMGMCRDAA AGMRYLESKN CIHRDLAARN CLVDLEHSVK
     ISDFGMSREE EEYIVSDGMK QIPVKWTAPE ALNFGKYTSL CDVWSYGILM WEIFSKGDTP
     YSGMTNSRAR ERIDTGYRMP TPKSTPEEMY RLMLQCWAAD AESRPHFDEI YNVVDALILR
     LDNSH
//
